Wells Fargo’s Lexaria Bioscience LEXX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.74K | Hold |
2,000
| – | – | ﹤0.01% | 5769 |
|
|
2025
Q1 | $3.42K | Sell |
2,000
-2,000
| -50% | -$3.42K | ﹤0.01% | 5617 |
|
|
2024
Q4 | $8.4K | Buy |
4,000
+1,500
| +60% | +$3.15K | ﹤0.01% | 5473 |
|
|
2024
Q3 | $7.63K | Sell |
2,500
-800
| -24% | -$2.44K | ﹤0.01% | 5444 |
|
|
2024
Q2 | $9.17K | Buy |
3,300
+2,227
| +208% | +$6.19K | ﹤0.01% | 5382 |
|
|
2024
Q1 | $3.9K | Buy |
1,073
+11
| +1% | +$40 | ﹤0.01% | 5539 |
|
|
2023
Q4 | $1.33K | Sell |
1,062
-24
| -2% | -$30 | ﹤0.01% | 5720 |
|
|
2023
Q3 | $1.09K | Buy |
1,086
+15
| +1% | +$15 | ﹤0.01% | 5806 |
|
|
2023
Q2 | $782 | Buy |
1,071
+2
| +0.2% | +$1 | ﹤0.01% | 6074 |
|
|
2023
Q1 | $2.91K | Buy |
1,069
+34
| +3% | +$92 | ﹤0.01% | 5850 |
|
|
2022
Q4 | $2.55K | Buy |
1,035
+1
| +0.1% | +$2 | ﹤0.01% | 5627 |
|
|
2022
Q3 | $2K | Buy |
1,034
+2
| +0.2% | +$4 | ﹤0.01% | 5827 |
|
|
2022
Q2 | $3K | Buy |
1,032
+2
| +0.2% | +$6 | ﹤0.01% | 5892 |
|
|
2022
Q1 | $3K | Buy |
1,030
+5
| +0.5% | +$15 | ﹤0.01% | 6230 |
|
|
2021
Q4 | $4K | Buy |
1,025
+1,000
| +4,000% | +$3.9K | ﹤0.01% | 6198 |
|
|
2021
Q3 | $0 | Sell |
25
-4
| -14% | – | ﹤0.01% | 6910 |
|
|
2021
Q2 | $0 | Hold |
29
| – | – | ﹤0.01% | 6810 |
|
|
2021
Q1 | $0 | Buy |
+29
| New | – | ﹤0.01% | 6747 |
|